Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenaco
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac sodium
Bromfenacum
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenac
Brand Names
Apo-bromfenac
Xibrom
Pred Phos-Gati-Brom
Auro-bromfenac
Eugia-bromfenac
Pred-Gati-Brom
Bromfenac Ophthalmic Solution 0.09%
Prolensa
Bromday
Bromfenac Ophthalmic Solution
Bromfenac Ophthalmic Solution, 0.07%
Bromfenac 0.075%
Bromfenac Ophthalmic Solution, 0.09%
Pred Phos - Brom
Bromsite 0.075%
Strenza Plus
Yellox
Pred-Brom
Bromfenac Sodium
Bromfenac
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682